256 related articles for article (PubMed ID: 28193736)
1. Down-regulation of CD73 on B cells of patients with viremic HIV correlates with B cell activation and disease progression.
Kim ES; Ackermann C; Tóth I; Dierks P; Eberhard JM; Wroblewski R; Scherg F; Geyer M; Schmidt RE; Beisel C; Bockhorn M; Haag F; van Lunzen J; Schulze Zur Wiesch J
J Leukoc Biol; 2017 May; 101(5):1263-1271. PubMed ID: 28193736
[TBL] [Abstract][Full Text] [Related]
2. Decreased frequency of CD73+CD8+ T cells of HIV-infected patients correlates with immune activation and T cell exhaustion.
Tóth I; Le AQ; Hartjen P; Thomssen A; Matzat V; Lehmann C; Scheurich C; Beisel C; Busch P; Degen O; Lohse AW; Eiermann T; Fätkenheuer G; Meyer-Olson D; Bockhorn M; Hauber J; van Lunzen J; Schulze Zur Wiesch J
J Leukoc Biol; 2013 Oct; 94(4):551-61. PubMed ID: 23709688
[TBL] [Abstract][Full Text] [Related]
3. Physical fitness modulates the expression of CD39 and CD73 on CD4
Dorneles GP; da Silva IM; Peres A; Romão PRT
J Cell Biochem; 2019 Jun; 120(6):10726-10736. PubMed ID: 30663116
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory Molecules PD-1, CD73 and CD39 Are Expressed by CD8
Smith CJ; Snyder CM
Front Immunol; 2021; 12():704862. PubMed ID: 34335618
[TBL] [Abstract][Full Text] [Related]
5. CD39/CD73 and the imbalance of Th17 cells and regulatory T cells in allergic asthma.
Wang LL; Tang HP; Shi GC; Wan HY; Tang W; Hou XX; Pan LN; Shi BY; Tao LQ
Mol Med Rep; 2013 Nov; 8(5):1432-8. PubMed ID: 24065069
[TBL] [Abstract][Full Text] [Related]
6. Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity.
Häusler SF; Montalbán del Barrio I; Strohschein J; Chandran PA; Engel JB; Hönig A; Ossadnik M; Horn E; Fischer B; Krockenberger M; Heuer S; Seida AA; Junker M; Kneitz H; Kloor D; Klotz KN; Dietl J; Wischhusen J
Cancer Immunol Immunother; 2011 Oct; 60(10):1405-18. PubMed ID: 21638125
[TBL] [Abstract][Full Text] [Related]
7. CD73
Seddiki N; Zaunders J; Phetsouphanh C; Brezar V; Xu Y; McGuire HM; Bailey M; McBride K; Hey-Cunningham W; Munier CML; Cook L; Kent S; Lloyd A; Cameron B; Fazekas de St Groth B; Koelsch K; Danta M; Hocini H; Levy Y; Kelleher AD
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477692
[TBL] [Abstract][Full Text] [Related]
8. Abnormal quantity and function of regulatory T cells in peripheral blood of patients with severe aplastic anemia.
Yan L; Fu R; Liu H; Wang H; Liu C; Wang T; Qi W; Guan J; Li L; Shao Z
Cell Immunol; 2015 Aug; 296(2):95-105. PubMed ID: 25906694
[TBL] [Abstract][Full Text] [Related]
9. CD4⁺CD73⁺ T cells are associated with lower T-cell activation and C reactive protein levels and are depleted in HIV-1 infection regardless of viral suppression.
Schuler PJ; Macatangay BJ; Saze Z; Jackson EK; Riddler SA; Buchanan WG; Hilldorfer BB; Mellors JW; Whiteside TL; Rinaldo CR
AIDS; 2013 Jun; 27(10):1545-55. PubMed ID: 24005375
[TBL] [Abstract][Full Text] [Related]
10. Phenotypical analysis of ectoenzymes CD39/CD73 and adenosine receptor 2A in CD4
Han L; Sugiyama H; Zhang Q; Yan K; Fang X; McCormick TS; Cooper KD; Huang Q
Australas J Dermatol; 2018 Feb; 59(1):e31-e38. PubMed ID: 28295154
[TBL] [Abstract][Full Text] [Related]
11. Dependence of immunoglobulin class switch recombination in B cells on vesicular release of ATP and CD73 ectonucleotidase activity.
Schena F; Volpi S; Faliti CE; Penco F; Santi S; Proietti M; Schenk U; Damonte G; Salis A; Bellotti M; Fais F; Tenca C; Gattorno M; Eibel H; Rizzi M; Warnatz K; Idzko M; Ayata CK; Rakhmanov M; Galli T; Martini A; Canossa M; Grassi F; Traggiai E
Cell Rep; 2013 Jun; 3(6):1824-31. PubMed ID: 23770243
[TBL] [Abstract][Full Text] [Related]
12. HIV "elite controllers" are characterized by a high frequency of memory CD8+ CD73+ T cells involved in the antigen-specific CD8+ T-cell response.
Carrière M; Lacabaratz C; Kök A; Benne C; Jenabian MA; Casartelli N; Hüe S; Hocqueloux L; Lelièvre JD; Lévy Y
J Infect Dis; 2014 May; 209(9):1321-30. PubMed ID: 24357632
[TBL] [Abstract][Full Text] [Related]
13. High expression of CD39/ENTPD1 in malignant epithelial cells of human rectal adenocarcinoma.
Zhang B; Cheng B; Li FS; Ding JH; Feng YY; Zhuo GZ; Wei HF; Zhao K
Tumour Biol; 2015 Dec; 36(12):9411-9. PubMed ID: 26113408
[TBL] [Abstract][Full Text] [Related]
14. Critical Role for the Adenosine Pathway in Controlling Simian Immunodeficiency Virus-Related Immune Activation and Inflammation in Gut Mucosal Tissues.
He T; Brocca-Cofano E; Gillespie DG; Xu C; Stock JL; Ma D; Policicchio BB; Raehtz KD; Rinaldo CR; Apetrei C; Jackson EK; Macatangay BJ; Pandrea I
J Virol; 2015 Sep; 89(18):9616-30. PubMed ID: 26178986
[TBL] [Abstract][Full Text] [Related]
15. CD39 expression on T lymphocytes correlates with severity of disease in patients with chronic lymphocytic leukemia.
Pulte D; Furman RR; Broekman MJ; Drosopoulos JH; Ballard HS; Olson KE; Kizer JR; Marcus AJ
Clin Lymphoma Myeloma Leuk; 2011 Aug; 11(4):367-72. PubMed ID: 21816376
[TBL] [Abstract][Full Text] [Related]
16. Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells.
Schuler PJ; Saze Z; Hong CS; Muller L; Gillespie DG; Cheng D; Harasymczuk M; Mandapathil M; Lang S; Jackson EK; Whiteside TL
Clin Exp Immunol; 2014 Aug; 177(2):531-43. PubMed ID: 24749746
[TBL] [Abstract][Full Text] [Related]
17. The metabolic milieu in melanoma: Role of immune suppression by CD73/adenosine.
Passarelli A; Tucci M; Mannavola F; Felici C; Silvestris F
Tumour Biol; 2019 Apr; 42(4):1010428319837138. PubMed ID: 30957676
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD73 slows down migration of skin dendritic cells, affecting the sensitization phase of contact hypersensitivity reactions in mice.
Neuberger A; Ring S; Silva-Vilches C; Schrader J; Enk A; Mahnke K
J Dermatol Sci; 2017 Sep; 87(3):292-299. PubMed ID: 28743609
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of CD73 associates with T cell exhaustion in AML patients.
Kong Y; Jia B; Zhao C; Claxton DF; Sharma A; Annageldiyev C; Fotos JS; Zeng H; Paulson RF; Prabhu KS; Zheng H
J Hematol Oncol; 2019 Apr; 12(1):40. PubMed ID: 31014364
[TBL] [Abstract][Full Text] [Related]
20. Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies.
Perrot I; Michaud HA; Giraudon-Paoli M; Augier S; Docquier A; Gros L; Courtois R; Déjou C; Jecko D; Becquart O; Rispaud-Blanc H; Gauthier L; Rossi B; Chanteux S; Gourdin N; Amigues B; Roussel A; Bensussan A; Eliaou JF; Bastid J; Romagné F; Morel Y; Narni-Mancinelli E; Vivier E; Paturel C; Bonnefoy N
Cell Rep; 2019 May; 27(8):2411-2425.e9. PubMed ID: 31116985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
